Atlas Trials

Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer

Clinical trial NCT01583322 · COMPLETED

Trial details

NCT number
NCT01583322
Sponsor
ARCAGY/ GINECO GROUP
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2012-06-01
Primary completion
2015-05-01
Enrollment
188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.